Hypertrophic Cardiomyopathy Associated with Mid-cavity Obstruction and High Left Intraventricular Pressure

Ramush A Bejiqi1, Ragip J Retkoceri, Hana Sh Bejiqi

  • 1Department of Cardiology, Pediatrics Clinic, University Clinical Centre of Kosova, Prishtina, Kosova.

Insights

This study details a rare pediatric idiopathic hypertrophic cardiomyopathy case with mid-cavity obstruction. Despite significant echocardiographic findings, the child experienced minimal growth and clinical symptoms.

Area of Science:

  • Pediatric Cardiology
  • Genetics and Molecular Biology
  • Developmental Biology

Background:

  • Idiopathic hypertrophic cardiomyopathy (IHC) is a primary cardiac disorder.
  • Mid-cavity obstruction and high intraventricular pressure are severe IHC manifestations.
  • Antenatal diagnosis of IHC is challenging but crucial for early management.

Observation:

  • A rare case of pediatric IHC with mid-cavity obstruction and high intraventricular peak pressure is presented.
  • The cardiomyopathy was diagnosed antenatally and monitored postnatally.
  • Despite numerous echocardiographic findings, the child exhibited minimal growth, development, and clinical signs.

Findings:

  • The case highlights a unique presentation of IHC with discordant clinical and echocardiographic findings.
  • Minimal postnatal clinical impact despite severe antenatal cardiac abnormalities.
  • Potential for novel genetic or molecular factors influencing disease expression.

Implications:

  • Understanding the pathophysiology of rare IHC variants is critical for accurate prognostication.
  • Further research into genetic and molecular underpinnings may reveal therapeutic targets.
  • This case underscores the importance of comprehensive postnatal monitoring in antenatally diagnosed cardiac conditions.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...